Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
To reduce the side effects of corticosteroid treatment, the administered dose of glucocorticoids (GCs) should be kept to a minimum while preserving therapeutically needed intracellular levels. Currently available assays to determine individual sensitivity to GCs are either imprecise or based on inhibition by GCs of lymphocyte proliferation following stimulation with phytohemagglutinin or other mitogens, which may influence the GC signal transduction pathway. Using the human lymphoblastoid cell line IM-9 as a model system, we studied whether the GC-induced increase of the mRNA encoding the 51-kDa FK506-binding protein (FKBP51) could be used for the development of a novel assay, ultimately to be used in native human peripheral blood mononuclear cells (PBMCs). GC addition to IM-9 cells resulted in a dose-dependent increase of FKBP51 mRNA levels within 2 h, followed by a further increase until 24 h. Northern blot analysis and real-time PCR yielded similar results. Coincubation of GCs with the GC receptor antagonist ORG 34116 or the protein synthesis inhibitor cycloheximide suggested a direct, GC receptor-mediated up-regulation of FKBP51 gene transcription. Expected differences in potency among different GCs could be readily demonstrated in this system. Extending our observations in IM-9 lymphoblasts to normal PBMCs, we found a dose-dependent increase of FKBP51 mRNA on ex vivo incubation of native human PBMCs with GCs, with a sensitivity of about 10(-9) M for dexamethasone. Moreover, dexamethasone ingestion increased FKBP51 mRNA in PBMCs in vivo, extending the use of this assay to the measurement of GC bioavailability. Finally, using this method we were able to demonstrate partial GC-insensitivity in a 6-month-old infant suffering from congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. We conclude that the induction of FKBP51 mRNA by GCs may be a suitable marker to assess individual GC sensitivity, the in vitro measurement of GC potency, and the in vivo determination of GC bioavailability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of FKBP5 is induced by glucocorticoids, thus forming an ultrashort intracellular negative-feedback loop for GR activity in response to stressor exposure (Vermeer et al, 2003)”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 induction by GR activation has been proposed as a molecular indicator of GR sensitivity (Ja ¨a ¨skela ¨inen et al, 2011;Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 is a heatshock protein 90 associated cochaperone of the GR and its expression is strongly induced by glucocorticoids via intronic steroid response elements as part of an intracellular short negative feedback loop for GR activity (Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
Citations
Cites
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00526-3 · Cited by 1,179
Quantification on the LightCycler
Rasmussen, R. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_3 · Cited by 892 · cited 1×
“This number was used to relate the initial quantity of cDNA of interest in each sample to one another (21).”
MethodTranscriptional cross-talk, the second mode of steroid hormone receptor action
Göttlicher, M., Heck, S., & Herrlich, P. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050242 · Cited by 388
Mechanism of glucocorticoid receptor down-regulation by glucocorticoids.
Rosewicz, S., McDonald, A. R., Maddux, B. A., Goldfine, I. D., Miesfeld, R. L., & Logsdon, C. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69104-5 · Cited by 322 · cited 1×
“On the other hand, it has been reported that GCs induce downregulation of GC receptor mRNA itself in IM-9 cells (41).”
BackgroundThe human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.
Güssow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., Kottman, A., & Ploegh, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3132 · Cited by 319 · cited 1×
“Primers used were 5 -AAAAGGCCAAGGAGCACAAC-3 and 5 -TTGAGGAGGGGCCGAGTTC-3 for the FKBP51 PCR (TIB-Molbiol, Berlin, Germany) and 5 -CCAGCAGAGAATGGAAAGTC-3 and 5 -GATGCTGCTTACATGTCTCG-3 for the 2-microglobulin ( 2m) PCR (20).”
MethodHuizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265 · cited 1×
“polymorphisms of the GC receptor (10, 11) and the avail-”
BackgroundSyndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235 · cited 1×
“Partial insensitivity to glucocorticoids can be caused by several mechanisms and has been described in many other patients (42).”
BackgroundNair, S. C., Rimerman, R. A., Toran, E. J., Chen, S., Prapapanich, V., Butts, R. N., & Smith, D. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.594 · Cited by 196 · cited 1×
“The immunophilin FKBP51 forms part of the Hsp90 steroid receptor complex (38) and has been shown to reduce the affinity of both the squirrel monkey and human GC receptor for its ligand when overexpressed (39, 40).”
BackgroundReynolds, P. D., Ruan, Y., Smith, D. F., & Scammell, J. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5429 · Cited by 184 · cited 1×
“The immunophilin FKBP51 forms part of the Hsp90 steroid receptor complex (38) and has been shown to reduce the affinity of both the squirrel monkey and human GC receptor for its ligand when overexpressed (39, 40).”
BackgroundFKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition
Baughman, G., Wiederrecht, G. J., Campbell, N. F., Martin, M. M., & Bourgeois, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4395 · Cited by 173 · cited 1×
“coding the 51-kDa FK506-binding protein (FKBP51) (16),”
Kannisto, S., Korppi, M., Remes, K., & Voutilainen, R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6336 · Cited by 164 · cited 1×
“A common clinical procedure is to test for suppression of the hypothalamic-pituitary-adrenal axis by graded doses of dexamethasone (25, 26).”
BackgroundRuiz, M., Lind, U., Gåfvels, M., Eggertsen, G., Carlstedt‐Duke, J., Nilsson, L., Holtmann, M., Stierna, P., Wikström, A., & Werner, S. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01323.x · Cited by 164 · cited 1×
“polymorphisms of the GC receptor (10, 11) and the avail-”
BackgroundPharmacodynamics and pharmacokinetics of inhaled glucocorticoids
Johnson, M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80217-x · Cited by 161 · cited 1×
“Besides differences in resorption or pharmacokinetic handling of the steroid (7), differences in cellular sensitivity may”
BackgroundBaughman, G., Wiederrecht, G., Chang, F., Martin, M. M., & Bourgeois, S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6307 · Cited by 138 · cited 2×
“FKBP51 mRNA is known to be induced by GCs (17), and we wanted to determine whether the mRNA response of this putative marker gene could be used in bioassays to determine GC potency and GC sensitivity of patient-derived lymphocytes ex vivo or in an assay to determine GC bioavailability.”
BackgroundKester, H. A., van der Leede, B.-J. M., van der Saag, P. T., & van der Burg, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16637 · Cited by 130 · cited 1×
“A 459-bp FKBP51 fragment (19) was used as probe; the fragment was amplified and purified after which 25 ng was labeled with (32)P dCTP using Rediprime labeling kit, according to the manufacturer’s protocol (Amersham Biosciences).”
MethodMolijn, G. J. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1799 · Cited by 125 · cited 1×
“inhibition of proliferation (28–30) or inhibition of cytokine production (31, 32).”
BackgroundDisturbed Neuroendocrine-Immune Interactions in Chronic Fatigue Syndrome1
Kavelaars, A., Kuis, W., Knook, L., Sinnema, G., & Heijnen, C. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6379 · Cited by 109
Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes
Kino, T., & Chrousos, G. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690437 · Cited by 109 · cited 1×
“however, can vary greatly from patient to patient (5, 6).”
BackgroundDeRijk, R. H. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.228 · Cited by 101 · cited 1×
“inhibition of proliferation (28–30) or inhibition of cytokine production (31, 32).”
BackgroundClinical aspects of glucocorticoid sensitivity
Lamberts, S. W. J., Huizenga, A. T. M., de Lange, P., de Jong, F. H., & Koper, J. W. (1996) · Steroids · doi:10.1016/0039-128x(96)00005-0 · Cited by 99 · cited 1×
“however, can vary greatly from patient to patient (5, 6).”
BackgroundWide Variation in Lymphocyte Steroid Sensitivity Among Healthy Human Volunteers1
Hearing, S. D., Norman, M., Smyth, C., Foy, C., & Dayan, C. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6156 · Cited by 96
Tissue Specificity of Glucocorticoid Sensitivity in Healthy Adults
Ebrecht, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3733 · Cited by 89 · cited 1×
“A common clinical procedure is to test for suppression of the hypothalamic-pituitary-adrenal axis by graded doses of dexamethasone (25, 26).”
BackgroundMolecular chaperones and subcellular trafficking of steroid receptors
DeFranco, D. B., Ramakrishnan, C., & Tang, Y. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00177-5 · Cited by 69
Boot, A. M., de Jongste, J. C., Verberne, A. A. P. H., Pols, H. A. P., & de Muinck Keizer-Schrama, S. M. P. F. (1997) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199712)24:6<379::aid-ppul1>3.0.co;2-c · Cited by 69 · cited 1×
“itary-adrenal axis suppression (3), and osteopenia (4).”
Squirrel Monkey Immunophilin FKBP51 Is a Potent Inhibitor of Glucocorticoid Receptor Binding1
Denny, W. B., Valentine, D. L., Reynolds, P. D., Smith, D. F., & Scammell, J. G. (2000) · Endocrinology · doi:10.1210/en.141.11.4107 · Cited by 66 · cited 2×
“Although the potency to reduce GC receptor affinity in humans is less than in squirrel monkeys (40), it is conceivable that constitutively elevated FKBP51 levels would induce a certain degree of GC insensitivity, but mutations in this gene, attenuating a supposed feedback mechanism, might be the cause of sustained GC…”
BackgroundSpahn, J. D., Landwehr, L. P., Nimmagadda, S., Surs, W., Leung, D. Y. M., & Szefler, S. J. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80194-1 · Cited by 65
Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoids
Saha, M., Laippala, P. J., & Lenko, H. (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb08854.x · Cited by 60 · cited 1×
“as growth retardation in children (2), hypothalamic-pitu-”
Noon, J. P., EVANS, C. E., Haynes, W. G., Webb, D. J., & Walker, B. R. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.114849.x · Cited by 48 · cited 1×
“This assay appears to be rather difficult to interpret, however, because it relies on the subjective assessment by a trained observer using a visual score (34).”
MethodEvaluation of the vasoconstrictive effects of topical steroids by laser-doppler-perfusion-imaging
Sommer, A. (1998) · Acta Dermato Venereologica · doi:10.1080/00015559850135751 · Cited by 46 · cited 1×
“Moreover, the skin-blanching assay appears to be influenced by the positioning of the tested limb (35) and the position at which the GC is applied on the limb (36).”
BackgroundChandrasekhar, S., Souba, W. W., & Abcouwer, S. F. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.2.l319 · Cited by 40 · cited 1×
“Possibly this intronic GRE is responsible for the mRNA induction, which would be unusual but not without precedent (24).”
BackgroundSteroid Receptor Number: Individual Variation and Downregulation by Treatment
Brönnegård, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s28 · Cited by 33 · cited 1×
“this respect, the number of GC receptors (8, 9), mutations, or”
BackgroundHypothalamic-Pituitary-Adrenal Axis in Corticosteroid-Resistant Bronchial Asthma
Lane, S. M., Atkinson, B., Swaminathan, R., & Lee, T. H. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564097 · Cited by 30 · cited 1×
“Despite several modifications and refinements, it is doubtful whether this test can ever be made sensitive enough to discriminate between different levels of GC sensitivity or insensitivity (27).”
BackgroundGrebe, S. K. G., Feek, C. M., Durham, J. A., Kljakovic, M., & Cooke, R. R. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2391059.x · Cited by 24 · cited 1×
“itary-adrenal axis suppression (3), and osteopenia (4).”
Andersson, O., Cassel, T. N., Grönneberg, R., Brönnegård, M., Stierna, P., & Nord, M. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70230-7 · Cited by 20 · cited 1×
“this respect, the number of GC receptors (8, 9), mutations, or”
BackgroundEffect of ORG 34116, a corticosteroid receptor antagonist, on hippocampal Ca2+ currents
Karst, H., de Kloet, E. R., & Joëls, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01363-0 · Cited by 13 · cited 1×
“receptor using the GC receptor antagonist ORG 34116 (22).”
MethodPostural Skin Colour Changes during the Corticosteroid Blanching Assay
Henry, F., Fumal, I., & Piérard, G. E. (1999) · Skin Pharmacology and Physiology · doi:10.1159/000066244 · Cited by 13 · cited 1×
“Moreover, the skin-blanching assay appears to be influenced by the positioning of the tested limb (35) and the position at which the GC is applied on the limb (36).”
BackgroundSteroid-resistant inflammatory bowel disease: A patient with non-compliance in the hospital
Delhaas, T., Jansen, M., Sinnema, G., Schryver, J. E. A. R. D., & de Meer, K. (1998) · European Journal of Pediatrics · doi:10.1007/pl00008287 · Cited by 4
Self-citation
Cited by
Machines and Mindlessness: Social Responses to Computers
Nass, C., & Moon, Y. (2000) · Journal of Social Issues · doi:10.1111/0022-4537.00153 · Cited by 4,022
Binder, E. B. (2008) · JAMA · doi:10.1001/jama.299.11.1291 · Cited by 1,362
“FKBP5 expression is induced by glucocorticoids as part of an intracellular ultrashort negative feedback loop for GR activity.(53) Overexpression of human FKBP5 in vitro reduces hormone binding affinity(54) and nuclear translocation of GR.”
BackgroundBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
“Another interesting feature of FKBP5 is that its expression is induced by steroids, including glucocorticoids as part of an intracellular ultra-short negative feedback loop for GR activity (Vermeer et al., 2003).”
BackgroundMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Metadata
- Authors
- Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M.
- Affiliations
- University Medical Center Utrecht (NL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-01
- Volume
- 88
- Issue
- 1
- Pages
- 277-284
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2087836842
- Cited by
- 285
- References
- 40
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 5 · 2023: 9 · 2022: 12 · 2021: 11 · 2020: 18 · 2019: 19 · 2018: 12 · 2017: 15 · 2016: 18 · 2015: 18 · 2014: 15 · 2013: 11 · 2012: 17
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- glucocorticoids, FKBP51, FKBP, glucocorticoid receptor, gene transcription, lymphocytes, peripheral blood mononuclear cells, glucocorticoid sensitivity, glucocorticoid potency, dexamethasone, congenital adrenal hyperplasia, 21-hydroxylase deficiency, cycloheximide
- MeSH terms
- Tacrolimus Binding Protein 5, Biological Availability, Computer Systems, Dexamethasone, Drug Resistance, Female, Glucocorticoids, Humans, Infant, Lymphocytes, Receptors, Glucocorticoid, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Blotting, Northern, Biomarkers, Polymerase Chain Reaction, Tacrolimus Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.